A
Aurora Therapeutics develops a scalable platform for personalized gene editing to address rare genetic diseases. The company leverages CRISPR technology to rapidly tailor treatments for specific genetic mutations that current therapies cannot reach. This approach aims to transform personalized gene editing from isolated successes into a broad therapeutic solution for millions of patients.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Aurora Therapeutics develops a scalable platform for personalized gene editing to address rare genetic diseases. The company leverages CRISPR technology to rapidly tailor treatments for specific genetic mutations that current therapies cannot reach. This approach aims to transform personalized gene editing from isolated successes into a broad therapeutic solution for millions of patients.